Micregen Ltd , United Kingdom
Title of Talk: Therapeutic Potential of MSC Secretomes Across Distinct Neurodegenerative Pathologies: Evidence from Alzheimer’s and Motor Neurone Disease Models
Category: Oral presentation
Robert obtained his PhD at the University of Reading, UK with his thesis specialising on the regenerative capabilities of the adult stem cell secretome, with a particular emphasis on its effect on skeletal muscle. Robert is a co-founder of Micregen and currently Director of R&D. Since 2019 Robert has managed and coordinated Micregen’s clinical manufacturing programme, preparing Micregen’s first therapeutic to enter a combined phase I/II clinical trial in the UK.
Empowering Innovation Through Global Conferences and Events.
© 2025 SciInov. All Rights Reserved.